Brain scan may sharpen tumor treatment choices

NCT ID NCT02631655

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether an 18F-FDOPA PET scan changes treatment decisions for people with high-grade gliomas (aggressive brain tumors) when standard MRI results are unclear. Researchers enrolled 110 patients and compared treatment plans before and after the scan. The goal was to see if the scan provides useful information to justify its cost.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

18F-FDOPA PET scan

What this could lead to

If successful, this could show that 18F-FDOPA PET helps doctors make better treatment decisions for brain tumor patients, potentially improving care and justifying its cost.

What could go wrong

This is a completed observational study, not a treatment trial. It only measures changes in decisions, not patient outcomes. The results may not apply to all brain tumor types or settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioblastoma malignant glioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Antoine Lacassagne

    Nice, 06000, France